🧪
hypothesis

FCER1G-Mediated Alternative Immune Signaling

Hypothesis

FCER1G-Mediated Alternative Immune Signaling

FCER1G activation to create TREM2-bypass immune signaling through alternative receptor pathways.
🧬 ['FCER1G']🩺 neurodegeneration🎯 Composite 48%💱 $0.56▼8.2%active
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 1 oppose
⚠ Thin Description Senate Quality Gates →
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite48%

🧪 Overview

FCER1G activation to create TREM2-bypass immune signaling through alternative receptor pathways

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["TREM2 Loss-of-Function<br/>R47H Variant or Shedding"]
    B["Microglial Phagocytic Deficit<br/>Amyloid Debris Accumulation"]
    C["FCER1G FcRgamma Expression<br/>Alternative Innate Immune Receptor"]
    D["FCER1G Activation<br/>IgG-Opsonized Substrate Binding"]
    E["ITAM Signaling via FcRgamma<br/>SYK LYN Kinase Activation"]
    F["Bypass of TREM2-TYROBP<br/>Alternative DAP10/DAP12 Axis"]
    G["Phagocytosis Restored<br/>TREM2-Independent Clearance"]
    H["Amyloid Plaque Burden Reduced<br/>Microglial Function Preserved"]
    A --> B
    B -.->|"impaired clearance"| H
    C --> D
    D --> E
    E --> F
    F --> G
    G --> H
    style F fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style H fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
TREM2 macrophage promotes cardiac repair in myocardial infarction by reprogramming metabolism via SLC25A53.
Cell Death Differ2024PMID:38182899medium
Supports
TREM2, microglia, and Alzheimer's disease.
Mech Ageing Dev2021PMID:33516818medium
Supports
TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge.
Neuron2020PMID:31902528medium
Supports
TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy.
Cell2020PMID:32783918medium
Supports
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.
Cell2017PMID:28802038medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — ['FCER1G']

No curated PDB or AlphaFold mapping for ['FCER1G'] yet. Search RCSB →

💉 Clinical Trials (1)

0
Active
0
Completed
0
Total Enrolled
Untitled TrialUnknown
Unknown·

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ['FCER1G'] →

No DepMap CRISPR Chronos data found for ['FCER1G'].

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0580
Events (7d)
1
Price History
▼8.2%

💾 Resource Usage

LLM Tokens
14,692
$0.0882
Total Cost
$0.0882

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF TREM2 is pharmacologically inhibited (anti-TREM2 blocking antibody) AND FCER1G is simultaneously overexpressed via plasmid transfection in microglia-like cells, THEN phagocytic activity and inflammTREM2 blockade alone will reduce phagocytosis by ~40-60% and alter cytokine profiles, but co-overexpression of FCER1G will rescue these functional deficits, res— no observation —pending0.68
IF FCER1G is genetically silenced (siRNA) in human macrophage cell lines, THEN phospho-SYK and phospho-SLP-65 signaling pathway activation will decrease by >50% compared to control cells within 48 houFCER1G knockdown will significantly reduce downstream ITAM pathway activation markers (phospho-SYK, phospho-BLAT, phospho-ERK1/2) while baseline NF-κB activity — no observation —pending0.72
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF FCER1G is genetically silenced (siRNA) in human macrophage cell lines, THEN phospho-SYK and phospho-SLP-65 signaling pathway activation will decrease by >50% compared to control cells within 48 hours using RAW 264.7 murine macrophages and human THP-1 monocyte-derived macrophages.
Predicted outcome: FCER1G knockdown will significantly reduce downstream ITAM pathway activation markers (phospho-SYK, phospho-BLAT, phospho-ERK1/2) while baseline NF-κB
Falsification: If FCER1G knockdown produces no significant change (<20% variation) in SYK/SLP-65 phosphorylation levels, the hypothesis that FCER1G mediates alternative immune signaling through ITAM-dependent pathwa
pendingconf 68%
IF TREM2 is pharmacologically inhibited (anti-TREM2 blocking antibody) AND FCER1G is simultaneously overexpressed via plasmid transfection in microglia-like cells, THEN phagocytic activity and inflammatory cytokine production (IL-6, TNF-α) will remain at baseline levels within 72 hours using BV-2 mi
Predicted outcome: TREM2 blockade alone will reduce phagocytosis by ~40-60% and alter cytokine profiles, but co-overexpression of FCER1G will rescue these functional def
Falsification: If TREM2 inhibition causes >60% reduction in phagocytic activity AND FCER1G overexpression fails to rescue this defect (remains <50% of baseline), the hypothesis that FCER1G creates TREM2-bypass alter
View on SciDEX ↗